NASDAQ: AXLA - Axcella Health Inc.

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Axcella Health Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Axcella Health Inc.

Axcella Health Inc. operates as a clinical-stage biotechnology company in the United States. The company treats complex diseases using endogenous metabolic modulators. Its product pipeline includes AXA1125 that is in Phase 2a clinical trial for long COVID therapy for patients, as well as Phase 2b clinical trial for treating non-alcoholic steatohepatitis; and AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016.

more details
Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2019-05-09
ISIN US05454B1052
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.axcellahealth.com
Цена ао 0.4009
Change price per day: 0% (0.4009)
Change price per week: 0% (0.4009)
Change price per month: 0% (0.4009)
Change price per 3 month: 0% (0.4009)
Change price per half year: 0% (0.4009)
Change price per year: 0% (0.4009)
Change price per 3 year: -76.69% (1.72)
Change price per 5 year: -83.3% (2.4)
Change price per year to date: 0% (0.4009)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 91.45 9
Yield EPS, % -97.23 0
Total: 5.8
More

Institutions Volume Share, %
Flagship Pioneering Inc. 1170059 39.69
Harbourvest Partners, LLC 248317 8.42
Schonfeld Strategic Advisors LLC 100600 3.41
FMR, LLC 66455 2.25
Vanguard Group Inc 32034 1.09
Geode Capital Management, LLC 11022 0.37
Blackrock Inc. 9903 0.34
Tower Research Capital LLC (TRC) 1225 0.04
JP Morgan Chase & Company 1073 0.04
Morgan Stanley 1004 0.03



Head Job title Payment Year of birth
Dr. Alison D. Schecter M.D. Pres of Strategy & Operations 525.53k 1964 (61 year)
Mr. David R. Epstein B.Sc., M.B.A. Consultant 228.34k 1962 (63 years)
Mr. Dan Kirby Sr. VP of Strategic Operations N/A
Mr. William R. Hinshaw Jr. Pres, CEO & Director 1969 (56 years)
Mr. Laurent Chardonnet Consultant 1965 (60 years)
Mr. Robert W. Crane Sr. VP & CFO 1959 (66 years)
Dr. Paul Fehlner J.D., Ph.D. Sr. VP, Chief Legal Officer & Corp. Sec. 1964 (61 year)
Ms. Virginia R. Dean Sr. VP & Chief People Officer 1966 (59 years)
Dr. Larry Bell Global Head of Regulatory Affairs & Pharmacovigilance and Sr. VP
Dr. Margaret James Koziel M.D. Sr. VP & Chief Medical Officer 1960 (65 years)

Address: United States, Cambridge. MA, 840 Memorial Drive - open in Google maps, open in Yandex maps
Website: https://www.axcellahealth.com